IJMS | Free Full-Text | New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial - The Lancet
PDF) The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge | Giacomo Cavallaro, Luca Filippi, and Monica Fumagalli - Academia.edu
RetinaToday | ROP: Epidemiology and Clinical Perspective
Retinopathy of Prematurity: A NICU Based Approach | IntechOpen
Latest Trends in Retinopathy of Prematurity | IJGM
Bevacizumab versus diode laser in stage 3 posterior retinopathy of prematurity - Moran - 2014 - Acta Ophthalmologica - Wiley Online Library
RetinaToday | ROP: Epidemiology and Clinical Perspective
RetinaToday | A New Horizon in ROP: The RAINBOW Study
Intraocular pressure effect of anti-vascular endothelial growth factor injection for aggressive posterior retinopathy of prematurity | Graefe's Archive for Clinical and Experimental Ophthalmology
Retinopathy of prematurity: from oxygen management to molecular manipulation | Molecular and Cellular Pediatrics | Full Text
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Treatment of retinopathy of prematurity (ROP)
Lower-dose bevacizumab may be effective in ROP treatment
RetinaToday | Clinical Research—Studies on Anti-VEGFs
Retinopathy of prematurity | PPT
The Role of Anti-vascular Endothelial Growth Factor Agents in the Management of Retinopathy of Prematurity - touchOPHTHALMOLOGY
The Role of Anti-vascular Endothelial Growth Factor Agents in the Management of Retinopathy of Prematurity - touchOPHTHALMOLOGY
Consensus on the Intravitreal Injection Technique among Infants with Retinopathy of Prematurity by the Vitreo-Retina Society of the Philippines – Philippine Journal Of Ophthalmology
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity | NEJM
Retinopathy of prematurity: from oxygen management to molecular manipulation | Molecular and Cellular Pediatrics | Full Text
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity | NEJM
APROP TREATMENT | PPT
